GBD 2019 Blindness and Vision Impairment Collaborators.Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob health. 2021;9:e144–e160. https://doi.org/10.1016/s2214-109x(20)30489-7.
Google Scholar
Taylor DJ, Hobby AE, Binns AM, Crabb DP. How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ open. 2016;6:e011504. https://doi.org/10.1136/bmjopen-2016-011504.
Google Scholar
Age-related macular degeneration: facts & figures, BrightFocus Foundation. 2019. Accessed 7 Mar 2025.
Zou M, Zhang Y, Chen A, Young CA, Li Y, Zheng D, et al. Variations and trends in global disease burden of age-related macular degeneration: 1990-2017. Acta Ophthalmol. 2021;99:e330–5. https://doi.org/10.1111/aos.14589.
Google Scholar
Xu X, Wu J, Yu X, Tang Y, Tang X, Shentu X. Regional differences in the global burden of age-related macular degeneration. BMC Public Health. 2020;20:410. https://doi.org/10.1186/s12889-020-8445-y.
Google Scholar
Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10. https://doi.org/10.1186/1471-2415-10-31.
Wang D, Jiang Y, He M, Scheetz J, Wang W. Disparities in the global burden of age-related macular degeneration: an analysis of trends from 1990 to 2015. Curr Eye Res. 2019;44:657–63. https://doi.org/10.1080/02713683.2019.1576907.
Google Scholar
Lin X, Lou L, Miao Q, Wang Y, Jin K, Shan P, et al. The pattern and gender disparity in global burden of age-related macular degeneration. Eur J Ophthalmol. 2021;31:1161–70. https://doi.org/10.1177/1120672120927256.
Google Scholar
GBD 2021 Diseases and Injuries Collaborators.Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–61. https://doi.org/10.1016/s0140-6736(24)00757-8.
Google Scholar
GBD 2021 Risk Factors Collaborators.Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (Lond, Engl). 2024;403:2162–203. https://doi.org/10.1016/s0140-6736(24)00933-4.
Google Scholar
Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–81. https://doi.org/10.1016/j.kint.2018.04.011.
Google Scholar
GBD 2017 Risk Factor Collaborators.Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (Lond, Engl). 2018;392:1923–94. https://doi.org/10.1016/s0140-6736(18)32225-6.
Google Scholar
Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob health. 2014;2:e106–116. https://doi.org/10.1016/s2214-109x(13)70145-1.
Google Scholar
Yang X, Chen H, Zhang T, Yin X, Man J, He Q, et al. Global, regional, and national burden of blindness and vision loss due to common eye diseases along with its attributable risk factors from 1990 to 2019: a systematic analysis from the global burden of disease study 2019. Aging. 2021;13:19614–42. https://doi.org/10.18632/aging.203374.
Google Scholar
Jiang B, Jiang C, Li J, Lu P. Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019. Front public health. 2023;11:1138428. https://doi.org/10.3389/fpubh.2023.1138428.
Google Scholar
WHO. Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
UN. Envision 2030: 17 goals to transform the world for persons with disabilities. Accessed 13 Apr 2022.
Kahloun R, Khairallah M, Resnikoff S, Cicinelli MV, Flaxman SR, Das A, et al. Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019;103:863–70. https://doi.org/10.1136/bjophthalmol-2018-312068.
Google Scholar
Khairallah M, Kahloun R, Flaxman SR, Jonas JB, Keeffe J, Leasher J, et al. Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010. Br J Ophthalmol. 2014;98:605–11. https://doi.org/10.1136/bjophthalmol-2013-304068.
Google Scholar
Joachim N, Mitchell P, Burlutsky G, Kifley A, Wang JJ. The incidence and progression of age-related macular degeneration over 15 years: the blue mountains eye study. Ophthalmology. 2015;122:2482–9. https://doi.org/10.1016/j.ophtha.2015.08.002.
Google Scholar
Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology. 2018;125:1913–28. https://doi.org/10.1016/j.ophtha.2018.05.028.
Google Scholar
Willeford KT, Rapp J. Smoking and age-related macular degeneration: biochemical mechanisms and patient support. Optom Vis Sci. 2012;89:1662–6. https://doi.org/10.1097/OPX.0b013e31826c5df2.
Google Scholar
Chung-Hall J, Craig L, Gravely S, Sansone N, Fong GT. Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. Tob control. 2019;28:s119–28. https://doi.org/10.1136/tobaccocontrol-2018-054389.
Google Scholar
Flor LS, Reitsma MB, Gupta V, Ng M, Gakidou E. The effects of tobacco control policies on global smoking prevalence. Nat Med. 2021;27:239–43. https://doi.org/10.1038/s41591-020-01210-8.
Google Scholar
Mehta MC, Narayanan R, Thomas Aretz H, Khanna R, Rao GN. The L V Prasad Eye Institute: a comprehensive case study of excellent and equitable eye care. Healthcare. 2020;8:100408. https://doi.org/10.1016/j.hjdsi.2019.100408.
Google Scholar
link
More Stories
The 6 Best Eye Health Supplements for Promoting Clear Vision
Top causes of visual impairment, satisfaction with eye care services, and associated factors among visually impaired patients attending an eye care center in Ethiopia
Revolutionary Cataract Surgery Technology Transforms Eye Care with Precision and Enhanced Patient Outcomes